Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?

Area of Science:

• Rheumatology
• Dermatology
• Pathology

Background:

• Calcinosis cutis involves insoluble calcium deposition in skin and subcutaneous tissues.
• It frequently manifests in autoimmune connective tissue diseases, notably systemic sclerosis and dermatomyositis.
• This dystrophic subtype occurs in damaged tissue with normal serum calcium and phosphate levels.

Purpose of the Study:

• To explore the characteristics and pathogenic mechanisms of calcinosis cutis in autoimmune connective tissue diseases.
• To differentiate calcinosis presentation and associations in systemic sclerosis versus dermatomyositis.
• To review treatment strategies and identify needs for improved therapeutic options.

Main Methods:

• Literature review and synthesis of existing research on calcinosis cutis.
• Comparative analysis of calcinosis in systemic sclerosis and dermatomyositis.
• Examination of associated autoantibodies and mineral composition.

Main Results:

• Calcinosis in juvenile dermatomyositis indicates active disease, while in adult dermatomyositis, it signifies chronic damage.
• Specific autoantibodies (anti-polymyositis/sclerosis, NXP-2, MDA5) and disease duration correlate with calcinosis.
• Calcinosis affects hands in systemic sclerosis and trunk/extremities in dermatomyositis; mineral compositions differ (hydroxyapatite vs. carbonate apatite).
• Pathogenesis involves vascular hypoxia (systemic sclerosis) and mitochondrial calcium release (dermatomyositis).

Conclusions:

• Calcinosis cutis is a significant manifestation of systemic sclerosis and dermatomyositis with distinct clinical and pathogenic features.
• Early aggressive treatment of underlying myositis in dermatomyositis may improve calcinosis outcomes.
• Further research into calcinosis pathogenesis is essential for developing effective treatments.